Wow—That’s a Lot of Protein!
The Life Technologies Partnership with Sino Biological—A Robust Proteomics Portfolio for Your Highly Dynamic Research
Combining trusted products and support from Life Technologies with leading proteomic technologies from Sino Biological allows us to deliver powerful research tools to scientists solving critical puzzles in life science research and drug discovery.
Together, we can bring powerful research tools to those customers who are answering critical research questions.
Mammalian cell expression systems are more likely to generate recombinant proteins with the proper folding, glycosylation, and other post-translational modifications. When Sino Biological is developing a new recombinant protein, this is the one of the first expression systems that they work with, so the closest to native protein can be used for research.
Here are a few of the research areas for which Sino Biological provides a wide selection of recombinant proteins:
- Over 1,000 recombinant proteins for cancer research
- Over 1,200 recombinant proteins for immunology research
- Over 700 recombinant proteins for signal transduction research
- Over 600 recombinant proteins for neuroscience research
- Over 600 recombinant proteins for stem cell research
- Over 800 recombinant proteins for cardiovascular research
- Over 700 enzymatic proteins
Sino Biological has over 170 recombinant influenza viral proteins, including hemagglutinin (HA), neuraminidase (NA), nucleoprotein (NP), M1, NS1, and NS2, which cover 79 strains of influenza A H1–H16 and influenza B.
About Sino Biological
Sino Biological, Inc. was founded in January 2007 in Beijing, China, by biotech pioneer and MIT professor Dr. Daniel I.C. Wang, along with his former student, Dr. Liangzhi Xie. Together with their team, they have created more than 10,000 products for researchers. This includes over 2,000 recombinant proteins and 2,000 antibodies. Sino Biological is quickly becoming a leading global biological solution specialist, offering a comprehensive set of quality, cost-effective reagents to accelerate life science research and development worldwide.
With cutting-edge protein production and second-generation rabbit monoclonal antibody technologies, Sino Biological has developed capabilities and capacities to produce over 1,000 recombinant protein bulk productions per year—all in house.